[go: up one dir, main page]

 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

Search Results (132)

Search Parameters:
Keywords = TCL1A

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
13 pages, 2632 KiB  
Article
Effects of Cultivar Factors on Fermentation Characteristics and Volatile Organic Components of Strawberry Wine
by Wei Lan, Mei Zhang, Xinyu Xie, Ruilong Li, Wei Cheng, Tingting Ma and Yibin Zhou
Foods 2024, 13(18), 2874; https://doi.org/10.3390/foods13182874 - 11 Sep 2024
Viewed by 341
Abstract
Strawberry wine production is a considerable approach to solve the problem of the Chinese concentrated harvesting period and the short shelf life of strawberries, but the appropriative strawberry cultivars for fermentation are still undecided. In this study, the strawberry juice and wines of [...] Read more.
Strawberry wine production is a considerable approach to solve the problem of the Chinese concentrated harvesting period and the short shelf life of strawberries, but the appropriative strawberry cultivars for fermentation are still undecided. In this study, the strawberry juice and wines of four typical strawberry cultivars named Akihime (ZJ), Sweet Charlie (TCL), Snow White (BX), and Tongzhougongzhu (TZ) were thoroughly characterized for their physicochemical indicators, bioactive compounds, and volatile organic components (VOCs) to determine the optimal strawberry cultivars for winemaking. The results showed that there were significant differences in the total sugar content, pH, total acid, and other physicochemical indexes in the strawberry juice of different cultivars, which further affected the physicochemical indexes of fermented strawberry wine. Moreover, the content of polyphenols, total flavonoids, vitamin C, and color varied among the four strawberry cultivars. A total of 42 VOCs were detected in the strawberry juice and wines using headspace solid-phase microextraction coupled with gas chromatography–mass spectrometry (HS-SPME-GC-MS), and 3-methyl-1-butanol, linalool, trans-2-pinanol, hexanoic acid, and hexanoic acid ethyl ester were the differential VOCs to identify the strawberry wine samples of different cultivars. Overall, strawberry cultivar ZJ had a relatively high VOC and bioactive compound content, indicating that it is the most suitable cultivar for strawberry wine fermentation. In addition to determining the relatively superior fermentation characteristics of cultivar ZJ, the results may provide a theoretical basis for the raw material quality control and quality improvement of strawberry wine. Full article
(This article belongs to the Section Food Engineering and Technology)
Show Figures

Figure 1

Figure 1
<p>Fermentation kinetics analysis of different cultivars of strawberry wine. (<b>A</b>) Brix; (<b>B</b>) residual sugar content; (<b>C</b>) ethanol content; (<b>D</b>) glucose content; (<b>E</b>) fructose content; BX: Snow White; TCL: Sweet Charlie; TZ: Tongzhougongzhu; ZJ: Akihime.</p>
Full article ">Figure 2
<p>Ethanol and residual sugar content of different cultivars of strawberry wine. (<b>A</b>) Ethanol content; (<b>B</b>) residual sugar content; BX: Snow White; TCL: Sweet Charlie; TZ: Tongzhougongzhu; ZJ: Akihime. Means with the same letter are not significantly different from each other (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 3
<p>Total acid content and pH of different cultivars of strawberry juice and wines. (<b>A</b>) pH; (<b>B</b>) total acid content; BX: Snow White; TCL: Sweet Charlie; TZ: Tongzhougongzhu; ZJ: Akihime. Means with the same letter are not significantly different from each other (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 4
<p>Total polyphenol, total flavonoid, and ascorbic acid content of different cultivars of strawberry juice and wines. (<b>A</b>) Total polyphenol content; (<b>B</b>) total flavonoid content; (<b>C</b>) ascorbic acid content; BX: Snow White; TCL: Sweet Charlie; TZ: Tongzhougongzhu; ZJ: Akihime. Means with the same letter are not significantly different from each other (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 5
<p>Coordinate analysis and variable importance in the projection (VIP) analysis of VOCs in strawberry juice and wines of different cultivars. (<b>A</b>) PCA; (<b>B</b>) OPLS-DA; (<b>C</b>) VIP value. BX: Snow White; TCL: Sweet Charlie; TZ: Tongzhougongzhu; ZJ: Akihime. Juice (m) samples, BXm: Snow White; TCLm: Sweet Charlie; TZm: Tongzhougongzhu; ZJm: Akihime.</p>
Full article ">Figure 6
<p>Cluster heatmap analysis based on differential VOCs in strawberry juice and wine samples. Wine samples, BX: Snow White; TCL: Sweet Charlie; TZ: Tongzhougongzhu; ZJ: Akihime. Juice (m) samples, BXm: Snow White; TCLm: Sweet Charlie; TZm: Tongzhougongzhu; ZJm: Akihime.</p>
Full article ">
15 pages, 532 KiB  
Article
Virulence Factors and Susceptibility to Ciprofloxacin, Vancomycin, Triclosan, and Chlorhexidine among Enterococci from Clinical Specimens, Food, and Wastewater
by Diana Brlek Gorski, Josipa Vlainić, Ivana Škrlec, Silvia Novak, Željka Novosel, Zrinka Biloglav, Vanda Plečko and Ivan Kosalec
Microorganisms 2024, 12(9), 1808; https://doi.org/10.3390/microorganisms12091808 - 1 Sep 2024
Viewed by 445
Abstract
Enterococcus faecalis and E. faecium are opportunistic pathogens commonly found in the microbiota of humans and other animals as well as in the environment. This article presents the results of antimicrobial susceptibility testing using phenotypic methods (broth microdilution and standardized disk diffusion) on [...] Read more.
Enterococcus faecalis and E. faecium are opportunistic pathogens commonly found in the microbiota of humans and other animals as well as in the environment. This article presents the results of antimicrobial susceptibility testing using phenotypic methods (broth microdilution and standardized disk diffusion) on selected clinical, food, and wastewater isolates of E. faecalis and E. faecium. The isolates were divided into subgroups based on their sensitivity to the following antibiotics: vancomycin (VAN) and ciprofloxacin (CIP), and biocides triclosan (TCL) and chlorhexidine (CHX). The study also investigated in vitro virulence factors, including biofilm formation ability, cell surface hydrophobicity (CSH) and β-hemolysis, to explore aspects of pathogenesis. In our study, regardless of the isolation source, VAN-resistant (VAN-R) and CIP-resistant (CIP-R) E. faecalis and E. faecium were detected. The highest proportion of CIP-R strains was found among clinical isolates of E. faecalis and E. faecium, with clinical E. faecium also showing the highest proportion of VAN-R strains. But the highest proportion of VAN-R E. faecalis strains was found in wastewater samples. The highest TCL MIC90 values for E. faecalis were found in wastewater isolates, while for E. faecium, the highest TCL MIC90 values were observed in food isolates. The highest CHX MIC90 values for both E. faecalis and E. faecium were identified in clinical specimens. The results obtained for E. faecalis did not indicate differences in TCL MIC and CHX MIC values with respect to sensitivity to VAN and CIP. Higher CHX MIC50 and CHX MIC90 values were obtained for CIP-R and VAN-R E. faecium. Among the tested isolates, 97.75% of the E. faecalis isolates produced biofilm, while 72.22% of the E. faecium isolates did so as well. In biofilm-forming strength categories III and IV, statistically significantly higher proportions of CIP-susceptible (CIP-S) and VAN-susceptible (VAN-S) E. faecalis were determined. In category III, there is no statistically significant difference in E. faecium CIP sensitivity. In category IV, we had a significantly higher proportion of CIP-R strains. On the other hand, the association between the moderate or strong category of biofilm formation and E. faecium VAN susceptibility was not significant. E. faecalis isolated from wastewater had a CSH index (HI) ≥ 50%, categorizing them as “moderate”, while all the other strains were categorized as “low” based on the CSH index. Among the E. faecalis isolates, cell surface hydrophobicity indices differed significantly across isolation sources. In contrast, E. faecium isolates showed similar hydrophobicity indices across isolation sources, with no significant difference found. Moreover, no correlation was found between the enterococcal cell surface hydrophobicity and biofilm formation in vitro. After anaerobic incubation, β-hemolytic activity was confirmed in 19.10% of the E. faecalis and 3.33% of the E. faecium strains. Full article
(This article belongs to the Section Antimicrobial Agents and Resistance)
Show Figures

Figure 1

Figure 1
<p>Cell surface hydrophobicity indices of <span class="html-italic">E. faecalis</span> (<b>A</b>) and <span class="html-italic">E. faecium</span> (<b>B</b>) isolates; ** <span class="html-italic">p</span> &lt; 0.001; **** <span class="html-italic">p</span> &lt; 0.0001; ns = not significant.</p>
Full article ">
22 pages, 5949 KiB  
Article
Deduplication-Aware Healthcare Data Distribution in IoMT
by Saleh M. Altowaijri
Mathematics 2024, 12(16), 2482; https://doi.org/10.3390/math12162482 - 11 Aug 2024
Viewed by 638
Abstract
As medical sensors undergo expeditious advancements, there is rising interest in the realm of healthcare applications within the Internet of Medical Things (IoMT) because of its broad applicability in monitoring the health of patients. IoMT proves beneficial in monitoring, disease diagnosis, and better [...] Read more.
As medical sensors undergo expeditious advancements, there is rising interest in the realm of healthcare applications within the Internet of Medical Things (IoMT) because of its broad applicability in monitoring the health of patients. IoMT proves beneficial in monitoring, disease diagnosis, and better treatment recommendations. This emerging technology aggregates real-time patient health data from sensors deployed on their bodies. This data collection mechanism consumes excessive power due to the transmission of data of similar types. It necessitates a deduplication mechanism, but this is complicated by the variable sizes of the data chunks, which may be either very small or larger in size. This reduces the likelihood of efficient chunking and, hence, deduplication. In this study, a deduplication-based data aggregation scheme was presented. It includes a Delimiter-Based Incremental Chunking Algorithm (DICA), which recognizes the breakpoint among two frames. The scheme includes static as well as variable-length windows. The proposed algorithm identifies a variable-length chunk using a terminator that optimizes the windows that are variable in size, with a threshold limit for the window size. To validate the scheme, a simulation was performed by utilizing NS-2.35 with the C language in the Ubuntu operating system. The TCL language was employed to set up networks, as well as for messaging purposes. The results demonstrate that the rise in the number of windows of variable size amounts to 62%, 66.7%, 68%, and 72.1% for DSW, RAM, CWCA, and DICA, respectively. The proposed scheme exhibits superior performance in terms of the probability of the false recognition of breakpoints, the static and dynamic sizes of chunks, the average sizes of chunks, the total attained chunks, and energy utilization. Full article
Show Figures

Figure 1

Figure 1
<p>System model.</p>
Full article ">Figure 2
<p>Average number of chunks.</p>
Full article ">Figure 3
<p>Average chunk size.</p>
Full article ">Figure 4
<p>Performances of all schemes under IC and fixed-sized windows.</p>
Full article ">Figure 5
<p>Likelihood of breakpoint failure.</p>
Full article ">Figure 6
<p>Throughput.</p>
Full article ">Figure 7
<p>Energy efficiency.</p>
Full article ">Figure 8
<p>Computational overhead.</p>
Full article ">Figure 9
<p>Energy consumption at collector devices (CDs).</p>
Full article ">Figure 10
<p>Energy consumption at sensing devices.</p>
Full article ">
13 pages, 667 KiB  
Article
Early Diagnosis of Amyloidosis and Cardiac Involvement through Carpal Tunnel Surgery and Predictive Factors
by María del Carmen Navarro-Saez, Carlos Feijoo-Massó, Alex Berenguer Sánchez, Tamara Parra Parente, Laura Guillamon Toran, Francesc Marcano-Fernández, Jaume Camara-Cabrera, Zully del Carmen Bravo Ferrer, Ricard Comet Monte and Xavier Calvet Calvo
J. Clin. Med. 2024, 13(15), 4328; https://doi.org/10.3390/jcm13154328 - 24 Jul 2024
Viewed by 685
Abstract
Background/Objectives: To determine the prevalence of amyloidosis through the analysis of synovial tissue and transverse carpal ligament (TCL) in patients undergoing surgery for carpal tunnel syndrome (CTS), detect predictive factors for the presence of amyloid, and assess cardiac involvement degree. Methods: [...] Read more.
Background/Objectives: To determine the prevalence of amyloidosis through the analysis of synovial tissue and transverse carpal ligament (TCL) in patients undergoing surgery for carpal tunnel syndrome (CTS), detect predictive factors for the presence of amyloid, and assess cardiac involvement degree. Methods: A prospective study with longitudinal cohort follow-up at a teaching hospital. Patients undergoing CTS surgery from 1 January 2019 to 31 May 2021 were included. Samples from synovial and TCL tissues were examined for amyloid presence. Multivariate analysis was used to detect predictive factors of the presence of amyloid. Patients with amyloid underwent echocardiography, laboratory analyses, and scintigraphy. Results: Two hundred and forty-six patients were included. The prevalence of amyloid was 11.4% in TCL and 12.6% in synovial tissues. Age (p = 0.035; OR 1.123), bilateral CTS symptoms (p = 0.022; OR 3.647), and trigger finger (p < 0.001; OR 3.537) were predictors of the presence of amyloid. Seventeen patients were diagnosed with transthyretin amyloidosis (ATTR) located in the carpus (no scintigraphic cardiac uptake or grade 0), one with light chain amyloidosis, eight with ATTR with cardiac involvement (grades 2–3), and five with ATTR in the carpus and scintigraphic uptake grade 1 (with normal echocardiogram and blood and urine tests). Conclusions: We detected amyloid in 12.6% of unselected consecutive patients who underwent CTS surgery. Biopsy in patients with CTS for amyloid detection, especially in elderly patients with bilateral symptoms and trigger finger, may be useful for the early diagnosis of amyloidosis, primarily due to transthyretin. Full article
(This article belongs to the Section Cardiology)
Show Figures

Figure 1

Figure 1
<p>Biopsy of ligament (10×): hematoxylin–eosin (<b>A</b>) Congo-red positive (<b>B</b>) and Congo-red permanganate positive (<b>C</b>); apple green birefringence of amyloid deposit with polarized light (<b>D</b>) Biopsy of synovial membrane (10×): hematoxylin–eosin (<b>E</b>) Congo-red positive (<b>F</b>) and Congo-red permanganate positive (<b>G</b>), positive immunohistochemical study for anti-transthyretin antibodies (<b>H</b>). The meaning of the arrows is where it marks positivity for the stains described in the caption.</p>
Full article ">Figure 2
<p>Receiver operating characteristic (ROC) curve for age as a predictor of amyloid positivity in carpal tunnel syndrome patients undergoing synovial membrane biopsy. (AUC = Area under curve).</p>
Full article ">
18 pages, 3503 KiB  
Article
Newcastle Disease Virus Virotherapy: Unveiling Oncolytic Efficacy and Immunomodulation
by Kawther A. Zaher, Jehan S. Alrahimi, Fatemah S. Basingab and Alia M. Aldahlawi
Biomedicines 2024, 12(7), 1497; https://doi.org/10.3390/biomedicines12071497 - 5 Jul 2024
Viewed by 774
Abstract
In virotherapy, cancer cells are eradicated via viral infection, replication, and dissemination (oncolysis). Background: This study aims to evaluate the oncolytic potential of Newcastle disease virus (NDV) against colon cancer and explore the immune response associated with its therapeutic effects. Methods: NDV was [...] Read more.
In virotherapy, cancer cells are eradicated via viral infection, replication, and dissemination (oncolysis). Background: This study aims to evaluate the oncolytic potential of Newcastle disease virus (NDV) against colon cancer and explore the immune response associated with its therapeutic effects. Methods: NDV was tested for its oncolytic potential in colon cancer cell lines using MTT assays and apoptosis assessments. Tumor-induced mice were treated with NDV, tumor cell lysate (TCL), or a combination of both. After the euthanasia of murine subjects, an assessment of oncolytic efficacy was performed through flow cytometry analysis of murine blood and tumor tissue, targeting CD83, CD86, CD8, and CD4. An ELISA was also performed to examine interferon-gamma levels, interleukin-4 levels, interleukin-12 levels, and interleukin-10 levels in serum and spleen homogenate. Results: Cell viability was low in HCT116 and HT-29, indicating a cytotoxic effect in the MTT assay. NDV+TCL recorded the highest rate of cell death (56.72%). NDV+TCL had accelerated cell death after 48 h, reaching 58.4%. The flow cytometry analysis of the blood and tumor of mice with induced tumor treated with combined treatment revealed elevated levels of CD83, CD86, CD8, and CD4 (76.3, 66.9, 83.7, and 14.4%, respectively). The ELISA levels of IFN-γ, IL-4, and IL-12 in serum and the spleen homogenate were elevated (107.6 ± 9.25 pg/mL). In contrast, the expression of IL-10 was significantly reduced (1 ± 0.79). Full article
(This article belongs to the Special Issue Oncolytic Viruses and Combinatorial Immunotherapy for Cancer)
Show Figures

Figure 1

Figure 1
<p>Photos of the upper two rows of HCT116 cells before and after treatment under the inverted microscope (<b>A</b>): Normal HCT-116 cells. (<b>B</b>): Cells 7 h post-infection, the cells lost their texture and shape. (<b>C</b>): Cells 24 h post-infection cell rounding and cell death. (<b>D</b>): Severe cell apoptosis, degradation, and syncytial cells are apparent. Lower row photos: HT-29 cells before and after treatment under the inverted microscope (<b>a</b>): Normal cell line. (<b>b</b>): 24 h post-infection shows cell rounding and multiple cell deaths. (<b>c</b>): Severe cell apoptosis and degradation (magnification is 40×, scale bar is 40 μm), Immunology unit, KFMRC, King Abdulaziz University.</p>
Full article ">Figure 2
<p>HCT116 tumor cell viability by MTT assay with different treatments from (<b>A</b>–<b>C</b>). HT-29 tumor cell viability by MTT assay with different treatments from (<b>D</b>–<b>F</b>). The bar plot represents the total percentages of cell viability from three independent experiments. The results are presented as the mean ± SD of three independent experiments.</p>
Full article ">Figure 3
<p>NDV apoptotic effect immunogenic cell death in colon cancer cells. (<b>A</b>) 10 PFU of NDV infected HCT116 cells in series one and with 4 μg/mL TCL in series two and both in series 3. (<b>B</b>) The results are 24, 48, and 72 hpt. Values are expressed as mean ± SEM. (n = 3, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.005).</p>
Full article ">Figure 4
<p>Oncolytic effects of the three treatments on tumor-induced mice (<b>A</b>) Dot plot of daily mice body weight after treatment. (<b>B</b>) Mice tumor weight after euthanasia. Values are expressed as mean ± SEM (n = 3) (repeated measures <span class="html-italic">p</span> = 0.047, n = 5).</p>
Full article ">Figure 5
<p>Photos were taken from mice that received 1.5 × 10<sup>7</sup> tumor cells from xenograft mice. (<b>A</b>): Shows the colorectum region of the positive control and NDV-treated group. (<b>B</b>): Histological section of colorectum region of NDV treated group. (<b>C</b>): Histological section of the colon of the TCL-treated group. (<b>D</b>): Histological section reveals carcinoma in positive control mice. (<b>E</b>,<b>F</b>): Histological section showing metastasis to the liver in positive control mice. The scale bar is 20 m, and the original magnification is ×40.</p>
Full article ">Figure 6
<p>Flow cytometric analysis of the five mouse groups’ BMCs for the expression of CD3<sup>+</sup>-CD4<sup>+</sup> (<b>A</b>), TCRγδ with CD3<sup>+</sup>-CD4<sup>+</sup> Gate (<b>B</b>), TCRγδ with CD3<sup>+</sup>-CD8<sup>+</sup> Gate (<b>C</b>). Data were analyzed using a one-way ANOVA test (n = 5, * <span class="html-italic">p</span> &gt; 0.05, ** <span class="html-italic">p</span> &gt; 0.01, and *** <span class="html-italic">p</span> &gt; 0.001, where the negative-control group is compared with the rest of the groups).</p>
Full article ">Figure 7
<p>Flow cytometric analysis of the five mouse groups’ BMCs for the expression of surface molecules on dendritic cells: CD11c CD11b chart (<b>A</b>), CD11c<sup>+</sup>- CD11b<sup>+</sup>- CD80+ Gate chart (<b>B</b>), CD11c<sup>+</sup>- CD11b<sup>+</sup>- CD86<sup>+</sup> Gate chart (<b>C</b>). Data were analyzed using a one-way ANOVA test (n = 5, * <span class="html-italic">p</span> &gt; 0.05, ** <span class="html-italic">p</span> &gt; 0.01, and *** <span class="html-italic">p</span> &gt; 0.001, where the negative-control group is compared with the rest of the groups).</p>
Full article ">Figure 8
<p>ELISA assessment of spleen homogenate to detect different cytokine levels: IFN-γ (<b>A</b>), IL-4 (<b>B</b>), IL-10 (<b>C</b>), and IL-12 (<b>D</b>). The results were analyzed using the one-way ANOVA test (n = 5, * <span class="html-italic">p</span> &gt; 0.05, ** <span class="html-italic">p</span> &gt; 0.01, and *** <span class="html-italic">p</span> &gt; 0.001, where the negative-control group is compared with the rest of the groups). The differences were significant, where * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.0006, and *** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">
17 pages, 3148 KiB  
Case Report
A New Histology-Based Prognostic Index for Aggressive T-Cell lymphoma: Preliminary Results of the “TCL Urayasu Classification”
by Hideaki Nitta, Haruko Takizawa, Toru Mitsumori, Hiroko Iizuka-Honma, Tomonori Ochiai, Chiho Furuya, Yoshihiko Araki, Maki Fujishiro, Shigeki Tomita, Akane Hashizume, Tomohiro Sawada, Kazunori Miyake, Mitsuo Okubo, Yasunobu Sekiguchi, Miki Ando and Masaaki Noguchi
J. Clin. Med. 2024, 13(13), 3870; https://doi.org/10.3390/jcm13133870 - 30 Jun 2024
Viewed by 590
Abstract
Background: Aggressive mature T-cell lymphoma (TCL) is a disease that carries a poor prognosis. Methods: We analyzed the expression of 22 tumor cell functional proteins in 16 randomly selected patients with TCL. Immunohistochemistry was performed in paraffin-embedded tumor tissue sections to determine the [...] Read more.
Background: Aggressive mature T-cell lymphoma (TCL) is a disease that carries a poor prognosis. Methods: We analyzed the expression of 22 tumor cell functional proteins in 16 randomly selected patients with TCL. Immunohistochemistry was performed in paraffin-embedded tumor tissue sections to determine the protein expression statuses in tumor cells. Results: Glucose-regulated protein 94 (GRP94), a protein that serves as a pro-survival component under endoplasmic reticulum (ER) stress in the tumor microenvironment, was significantly associated with a shortened survival. Furthermore, significant differences were observed when GRP94 was combined with six other factors. The six factors were (1) programmed cell death-ligand 1 (PD-L1); (2) programmed cell death 1 (PD-1); (3) aldo-keto reductase family 1 member C3 (AKR1C3); (4) P53, a tumor suppressor; (5) glucose-regulated protein 78 (GRP78), an ER stress protein; and (6) thymidine phosphorylase (TP). Based on the combination of GRP94 and the six other factors expressed in the tumors, we propose a new prognostic classification system for TCL (TCL Urayasu classification). Group 1 (relatively good prognosis): GRP94-negative (n = 6; median OS, 88 months; p < 0.01); Group 2 (poor prognosis): GRP94-positive, plus expression of two of the six factors mentioned above (n = 5; median OS, 25 months; p > 0.05); and Group 3 (very poor prognosis): GRP94-positive, plus expression of at least three of the six factors mentioned above (n = 5; median OS, 10 months; p < 0.01). Conclusions: Thus, the TCL Urayasu prognostic classification may be a simple, useful, and innovative classification that also explains the mechanism of resistance to treatment for each functional protein. If validated in a larger number of patients, the TCL Urayasu classification will enable a targeted treatment using selected inhibitors acting on the abnormal protein found in each patient. Full article
(This article belongs to the Special Issue Hematologic Malignancies: Treatment Strategies and Future Challenges)
Show Figures

Figure 1

Figure 1
<p>Overall survival of TCL patients with and without prognostic factors—comparison of the Kaplan–Meier survival curves and disease/existing prognostic factors between 2 groups (log-rank test)—+: positive; −: negative. (<b>A</b>) TCL overall survival (OS) (<span class="html-italic">n</span> = 16). The median OS after initial treatment with CHOP-like regimens was 33.5 months. (<b>B</b>) ALCL, <span class="html-italic">n</span> = 3; AITL, <span class="html-italic">n</span> = 6; PTCL NOS, <span class="html-italic">n</span> = 7; <span class="html-italic">p</span> &lt; 0.05. The median OS values indicated a poor prognosis in the ALCL patients in this study; the OS was about 8 months in the patients with ALCL, about 34 months in the patients with AITL, and about 72 months in the patients with PTCL-NOS, (<b>C</b>) A conventional poor prognostic factor, IPI high positive, <span class="html-italic">n</span> = 7; negative, <span class="html-italic">n</span> = 9; <span class="html-italic">p</span> &gt; 0.05. No significant difference was observed in the IPI among the groups. (<b>D</b>) No significant differences were observed in the distribution of the conventional poor prognostic factors in the high-risk PIT groups (Groups 2, 3, and 4; <span class="html-italic">n</span> = 4) as compared with the other groups (<span class="html-italic">n</span> = 12). No significant differences were observed in PIT among the groups (<span class="html-italic">p</span> &gt; 0.05). (<b>E</b>) CR-positive and CR-negative patients (<span class="html-italic">n</span> = 8 in both groups). Those who showed CR had a significantly better prognosis (<span class="html-italic">n</span> = 8; median OS, about 72 months; <span class="html-italic">p</span> &lt; 0.01). (<b>F</b>) Non-CR plus relapse within 1 year: positive, <span class="html-italic">n</span> = 10; negative, <span class="html-italic">n</span> = 6, <span class="html-italic">p</span> &lt; 0.01. Patients with non-CR or relapse within 1 year had a significantly worse prognosis (<span class="html-italic">n</span> = 10; median OS, 13.5 months; <span class="html-italic">p</span> &lt; 0.01).</p>
Full article ">Figure 2
<p>Overall survival in TCL patients with and without prognostic factors—comparison of the Kaplan–Meier survival curves and prognostic factors, positive/negative immunostaining between Group 2 and Group 3 (log-rank test). (<b>A</b>,<b>B</b>) show the results of comparisons among 3 groups, and C to F show the results of comparisons between 2 groups. (<b>A</b>) GRP94+, CR1+, <span class="html-italic">n</span> = 2; GRP94+, CR−, <span class="html-italic">n</span> = 8; GRP94−, CR+, <span class="html-italic">n</span> = 6; <span class="html-italic">p</span> &lt; 0.01. GRP94-positive patients showed a non-CR treatment response, resulting in a poor prognosis. (<b>B</b>) GRP94-positive patients with relapse (<span class="html-italic">n</span> = 10), poor prognosis with a median OS of 13.5 months (<span class="html-italic">p</span> &lt; 0.01). GRP94-negative patients without relapse (<span class="html-italic">n</span> = 6), relatively good prognosis with a median OS of 102 months (<span class="html-italic">p</span> &lt; 0.01). A total of 10 patients, consisting of 6 patients who showed a non-CR treatment response after the initial therapy and 4 patients who developed relapse within 1 year, were identical to the 10 patients showing positive tumor staining for GRP94. GRP94-positive patients showed a “non-CR” treatment response after the initial therapy or developed relapse within 1 year, resulting in a poor prognosis. In the tumor microenvironment, GRP94 expression is associated with cell survival of the TCL cells and leads to a poor prognosis. In order to overcome various stressful conditions, such as altered cellular metabolism and acidosis, TCL cells survive and lead to a poor prognosis. (<b>C</b>) PD-L1-positive patients (<span class="html-italic">n</span> = 4, median OS, 5.5 months, <span class="html-italic">p</span> &lt; 0.01); PD-L1-negative patients (<span class="html-italic">n</span> = 12, median OS, 50 months, <span class="html-italic">p</span> &lt; 0.01). PD-L1 positivity allows TCL cells to proliferate by escaping the surveillance mechanism, which results in a poor prognosis. (<b>D</b>) AKR1C3-positive patients (<span class="html-italic">n</span> = 6, median OS, 10 months: <span class="html-italic">p</span> &lt; 0.01); AKR1C3-negative patients (<span class="html-italic">n</span> = 10, median OS, 62 months; <span class="html-italic">p</span> &lt; 0.01). AKR1C3 expression in TCL cells decreases the intracellular metabolism of HO of the CHOP regimen drugs, attenuating their cytotoxic activity against the TCL cells and making the disease refractory, which results in a poor prognosis. (<b>E</b>) TP-positive patients (<span class="html-italic">n</span> = 3, median OS, 6 months; <span class="html-italic">p</span> &lt; 0.01); TP-negative patients (<span class="html-italic">n</span> = 13, median OS, 56 months; <span class="html-italic">p</span> &lt; 0.01). TP expression is mainly linked to antiapoptotic and angiogenic activities, leading to a poor prognosis. (<b>F</b>) CYP2B6-positive patients (<span class="html-italic">n</span> = 4, median OS, 13.5 months; <span class="html-italic">p</span> &lt; 0.05); CYP2B6-negative patients (<span class="html-italic">n</span> = 12, median OS, 46 months; <span class="html-italic">p</span> &lt; 0.01).</p>
Full article ">Figure 3
<p>Overall survival of TCL patients with and without prognostic factors—comparison of the Kaplan–Meier survival curves and positive/negative immunostainings among 3 groups (log-rank test). (<b>A</b>) Patients showing positive tumor staining for GRP94 and PD-L1; patients showing positive tumor staining for GRP94, but negative staining for PD-L1; patients with tumors showing negative staining for both GRP94 and PD-L1. Thus, expression of GRP94 on the tumor cell surface is associated with a poor prognosis. Expression of PD-L1 on the cell surface also leads to a poor prognosis. (<b>B</b>) Patients showing positive tumor staining for GRP94 and TP; patients showing positive tumor staining for GRP94, but negative staining for TP; patients with tumors showing negative staining for both GRP94 and TP. TP expression is associated with a poor prognosis. (<b>C</b>) Patients showing positive tumor staining for GRP94 and AKR1C3; patients showing positive tumor staining for GRP94, but negative staining for AKR1C3; patients with tumors showing negative staining for both GRP94 and AKR1C3. These activities lead to a poor prognosis. (<b>D</b>) Patients showing positive tumor staining for P53 and GRP94; patients with tumors showing negative staining for P53, but positive staining for GRP94; patients with tumors showing negative staining for both P53 and GRP94. P53 mutations are associated with a poor prognosis. (<b>E</b>) Patients with tumors showing negative staining for PD-1, but positive staining for GRP94; patients showing positive tumor staining for PD-1 and GRP94; patients showing negative staining for PD-1, but positive staining for GRP94; patients showing positive tumor staining for PD-1, but negative staining for GRP94; patients showing negative staining for both PD-1 and GRP94. PD-1 signaling suppresses the growth of TCL. (<b>F</b>) Patients showing positive tumor staining for GRP78 and GRP94; patients showing positive tumor staining for GRP78, but negative staining for GRP94; patients showing negative tumor staining for both GRP78 and GRP94; patients with tumors showing negative staining for GRP78, but positive staining for GRP94. Patients showing positive tumor staining for both the ER stress proteins GRP78 and GRP94 show a poor prognosis.</p>
Full article ">Figure 4
<p>Overall survival of TCL patients with and without prognostic factors (TCL Urayasu classification)—comparison of the Kaplan–Meier survival curves among 3 groups (log-rank test). (<b>A</b>) TCL Urayasu Group 1. The median OS shown in <a href="#jcm-13-03870-f001" class="html-fig">Figure 1</a>A almost doubled from 33.5 months, which is a relatively good prognosis for patients with TCL. For Group 2 and Group 3, the median OS was about 40% of the 33.5 months in the overall patient population, indicating a relatively poor prognosis. (<b>B</b>) TCL Urayasu Group 2 and other groups. There was no significant difference in the OS between positive groups and the negative group. The median OS in the overall patient population was about 75% of 33.5 months, indicating a relatively poor prognosis for Group 2. (<b>C</b>) TCL Urayasu Group 3 and other groups. The median OS in the overall patient population was about 30% of 33.5 months, indicating a poor prognosis for Group 3. In Group 1 and Group 2, the median OS was 53 months, being about 1.6 times that of the median OS in the overall patient population. This indicates a relatively good prognosis. (<b>D</b>) TCL Urayasu Group 3 vs. PTCL-NOS. Group 3 with PTCL-NOS and Group 3 without PTCL-NOS: Group 3 with either disease type had a poor prognosis. Group 1 or 2, with PTCL-NOS and Group 3, without PTCL-NOS. (<b>E</b>) TCL Urayasu Group 3 vs. AITL. Group 3 with AITL and Group 3 without AITL: the median OS was about 10 months in both groups. Group 1 or 2, with AITL: the median OS was about 33.5 months, which was the same as that for the OS in all patients. Patients with AITL were classified into either Group 1 or 2, and their prognosis was intermediate. Group 1 or 2, without AITL: the median OS was about 104 months. (<b>F</b>) TCL Urayasu Group 3 vs. ALCL. Group 3 with ALCL: the median OS was about 6 months. All patients with ALCL were classified into Group 3, and thus had a poor prognosis. Group 3 without ALCL: these patients had PTCL-NOS and had a median OS of about 10 months. Group 1 or 2, with ALCL and Group 1 or 2, without ALCL: the median OS was about 53 months.</p>
Full article ">Figure 5
<p>HPI (TCL Urayasu classification) Group 3 (the very poor prognosis group) Case: A 33-year-old woman diagnosed with stage IIA ALK-positive ALCL (low-intermediate IPI (IPIe), PIT-Group 1). ALK positivity is generally associated with a good prognosis. However, this patient developed resistance to both CHOP and ESHAP regimens, and died after only about 2 months of treatment. The diagnosis was ALCL. Her ALCL showed positive staining for GRP94 (shown in 8) and 3 (PD-L1, TP, and GRP78, shown in 10, 12, and 20) of the other 6 poor prognostic factors (PD-L1, TP, AKR1C3, P53, PD1, and GRP78). In the tumor microenvironment, expression of PD-L1 on the cell surface blocks the immune checkpoint molecules, allowing the tumor to grow. TP is involved in starvation resistance, angiogenesis, invasion, and metastasis. GRP78 allows the tumors to overcome various stressful conditions, such as hypoxia, hypoglycemia, dysregulation of homeostasis, altered cell metabolism, and acidosis, which results in treatment resistance.</p>
Full article ">Figure 6
<p>Relationships between the prognostic factors in the TCL and LBCL Urayasu classifications. The relationships between the 7 factors involved in treatment resistance in the TCL Urayasu classification and the 6 factors involved in treatment resistance in the LBCL Urayasu classification are summarized in the following set diagram Of the 7 TCL factors, the 4 factors unique to the TCL classification are the immune checkpoint molecules (PD-1 and PD-L1) serving as pro-survival components in the microenvironment, and TP and GRP78, both of which are involved in angiogenesis, invasion, and metastasis in order to overcome stressful conditions, such as hypoxia, hypoglycemia, and starvation resistance. On the other hand, the other 3 factors, which are common to both the TCL and LBCL classifications, are highly important, and consist of GRP94, AKR1C3 (an enzyme that inactivates the activity of chemotherapeutic agents by metabolizing HO), and P53 (product of a tumor suppressor gene). On the other hand, the 3 factors unique to the LBCL Urayasu classification are CYP3A4 (an enzyme that metabolizes and inactivates the activities of the CHOP regimen), MDR1, and MRP1, with both the latter being HO efflux pumps.</p>
Full article ">
14 pages, 1652 KiB  
Article
Demand Management for Manufacturing Loads Considering Temperature Control under Dynamic Electricity Prices
by Yan Yang, Junhui Yu and Hengrui Ma
Processes 2024, 12(6), 1252; https://doi.org/10.3390/pr12061252 - 18 Jun 2024
Viewed by 435
Abstract
Demand response (DR) can provide extra scheduling flexibility for power systems. Different from industrial and residential loads, the production process of manufacturing loads includes multiple production links, and complex material flow and energy flow are closely coupled, which can be seen as a [...] Read more.
Demand response (DR) can provide extra scheduling flexibility for power systems. Different from industrial and residential loads, the production process of manufacturing loads includes multiple production links, and complex material flow and energy flow are closely coupled, which can be seen as a typical nondeterministic polynomial-time (NP) hard problem. In addition, there is a coupling effect between the temperature-controlled loads (TCLs) and the manufacturing loads, which has often been ignored in previous research, resulting in conservative electricity consumption planning. This paper proposes an optimal demand management for the manufacturing industry. Firstly, the power consumption characteristics of manufacturing loads are analyzed in detail. A state task network (STN) is introduced to decouple the relationship between energy and material flow in each production link. Combining STN and production equipment parameters, a general MILP model is constructed to describe the whole production process of the manufacturing industry. Then, a mathematical model of the TCLs considering a comfortable human degree is established. Fully considering the electricity consumption behavior of equipment and TCLs, the model predictive control (MPC) method is adopted to generate the optimal scheduling plan. Finally, an actual seat production enterprise is used to verify the feasibility and effectiveness of the proposed demand management strategy. Full article
(This article belongs to the Section Energy Systems)
Show Figures

Figure 1

Figure 1
<p>Schematic diagram of air source heat pump operation.</p>
Full article ">Figure 2
<p>Dynamic electricity price information.</p>
Full article ">Figure 3
<p>Node power of each task of car seat production in the current scenario.</p>
Full article ">Figure 4
<p>Yield of car seats per hour in the current scenario.</p>
Full article ">Figure 5
<p>Working state of air source heat pump under different conditions.</p>
Full article ">Figure 6
<p>Power of welding coating 1 under different scheduling time scales.</p>
Full article ">
9 pages, 3671 KiB  
Article
Chromogenic Approach for Oxygen Sensing Using Tapered Coreless Optical Fibre Coated with Methylene Blue
by Rahul Kumar and Neil Wight
Metrology 2024, 4(2), 295-303; https://doi.org/10.3390/metrology4020018 - 12 Jun 2024
Viewed by 800
Abstract
In this paper, a Methylene Blue (MB)-coated tapered coreless (TCL) optical fibre sensor is proposed and experimentally investigated for oxygen sensing in the near-infrared (NIR) wavelength range of 993.5 nm. The effect of TCL diameter and MB sol–gel coating thickness on the sensitivity [...] Read more.
In this paper, a Methylene Blue (MB)-coated tapered coreless (TCL) optical fibre sensor is proposed and experimentally investigated for oxygen sensing in the near-infrared (NIR) wavelength range of 993.5 nm. The effect of TCL diameter and MB sol–gel coating thickness on the sensitivity of the sensor was also investigated. A maximum sensitivity of 0.19 dB/O2% in the oxygen concentration range of 0–37.5% was achieved for a TCL fibre sensor with a 2 µm taper waist diameter and a 0.86 µm MB sol–gel coating thickness, with a response time of 4 min. The sensor provides reproducible results even after 7 days and is shown to be highly selective to oxygen compared to argon and ethanol at the same concentration. Full article
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>) Schematic diagram of functionalised tapered coreless (TCL) fibre optic sensor showing original 125 µm diameter and fabricated waist region created using the heat and pull technique, and (<b>b</b>) SEM images of fabricated MB sol–gel-coated TCL fibre structure, with LHS image showing the coating thickness and RHS image showing the waist diameter and uniformity of the MB sol–gel coating. (<b>c</b>) SEM image showing the lengths of transition and waist regions for a TCL fibre structure with a 4 µm waist diameter.</p>
Full article ">Figure 2
<p>Schematic diagram of the experimental apparatus showing the sealed gas chamber, carrier and test gas flow inlets, and chamber gas outlet, alongside the broadband optical source and optical spectrum analyser used to provide and detect NIR light.</p>
Full article ">Figure 3
<p>Intensity variation for different concentrations of oxygen using a fabricated TCL fibre optic sensor with a 2 µm tapering diameter and a 0.86 µm MB sol–gel coating thickness: (<b>a</b>) with respect to time, and (<b>b</b>) spectral response. A reduction in intensity as oxygen concentration increases is clearly shown, as well as the response time of the sensor to changes in the oxygen concentration.</p>
Full article ">Figure 4
<p>Change in intensity as a function of changing oxygen concentrations, for fabricated 2 and 4 µm tapered-waist-diameter TCL fibre optic sensors, coated with 0.39, 0.69, and 0.89 µm thicknesses of MB sol–gel. Intensity changes for an un-tapered 125 µm coreless fibre optic sensor with a 0.86 µm MB sol–gel coating thickness are also shown for reference.</p>
Full article ">Figure 5
<p>Effect of coating thickness and diameter of TCL optical fibre sensor on its sensitivity, revealing sensitivity to oxygen concentration for increasing MB sol–gel coating thickness.</p>
Full article ">Figure 6
<p>Selectivity of MB sol–gel-coated TCL fibre optic sensor with 2 µm tapering diameter and coating thickness of 0.86 µm for oxygen versus argon and ethanol.</p>
Full article ">Figure 7
<p>Repeatability for TCL fibre optic sensor with 2 µm tapering diameter and coating thickness of 0.86 µm after exposure to ambient conditions for 7 days.</p>
Full article ">
14 pages, 5273 KiB  
Article
Optimization of In Vitro Th17 Polarization for Adoptive Cell Therapy in Chronic Lymphocytic Leukemia
by Wael Gamal, Melanie Mediavilla-Varela, Angimar Uriepero-Palma, Javier Pinilla-Ibarz and Eva Sahakian
Int. J. Mol. Sci. 2024, 25(12), 6324; https://doi.org/10.3390/ijms25126324 - 7 Jun 2024
Viewed by 983
Abstract
Although preclinical investigations have shown notable efficacy in solid tumor models utilizing in vitro-differentiated Th17 cells for adoptive cell therapy (ACT), the potential benefits of this strategy in enhancing ACT efficacy in hematological malignancies, such as chronic lymphocytic leukemia (CLL), remain unexplored. CLL [...] Read more.
Although preclinical investigations have shown notable efficacy in solid tumor models utilizing in vitro-differentiated Th17 cells for adoptive cell therapy (ACT), the potential benefits of this strategy in enhancing ACT efficacy in hematological malignancies, such as chronic lymphocytic leukemia (CLL), remain unexplored. CLL is a B-cell malignancy with a clinical challenge of increased resistance to targeted therapies. T-cell therapies, including chimeric antigen receptor (CAR) T cells, have demonstrated limited success in CLL, which is attributed to CLL-mediated T-cell dysfunction and skewing toward immunosuppressive phenotypes. Herein, we illustrate the feasibility of polarizing CD4+ T cells from the Eμ-TCL1 murine model, the most representative model for human CLL, into Th17 phenotype, employing a protocol of T-cell activation through the inducible co-stimulator (ICOS) alongside a polarizing cytokine mixture. We demonstrate augmented memory properties of in vitro-polarized IL-17-producing T cells, and preliminary in vivo persistence in leukemia-bearing mice. Our findings gain translational relevance through successful viral transduction of Eμ-TCL1 CD4+ T cells with a CD19-targeted CAR construct during in vitro Th17 polarization. Th17 CAR T cells exhibited remarkable persistence upon encountering antigen-expressing target cells. This study represents the first demonstration of the potential of in vitro-differentiated Th17 cells to enhance ACT efficacy in CLL. Full article
(This article belongs to the Special Issue Immunotherapy: A New Perspective in Cancer Treatment)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Optimization of ICOS-based co-stimulation for in vitro Th17 polarization. Bulk CD4<sup>+</sup> T cells from wild-type (WT) spleens were activated using anti-CD28 or anti-ICOS-based dynabeads for 5 days under Th17 polarizing conditions, then subjected to 4–5 h PMA/ionomycin stimulation followed by flow cytometry staining. (<b>A</b>) Light microscopy images at 4× magnification comparing T-cell activation clusters at day 5 using the different activation conditions. (<b>B</b>) Frequency of live cells as indicated by near-IR fluorescent reactive dye using flow cytometry. (<b>C</b>) Representative flow cytometry dot plots and tabulated results for IL-17A production using the different activation beads. (<b>D</b>) Quantification of relative IL-17A MFI (mean fluorescence intensity). (<b>E</b>,<b>F</b>) Representative flow cytometry histograms and tabulated results for intracellular RORγt (<b>E</b>) and surface CD25 (<b>F</b>) expression levels relative to control (anti-CD28 activation condition). (<b>G</b>) Frequency of IFNγ positive cells as indicated by flow cytometry. (<b>H</b>) Representative dot plots and tabulated results of T-cell memory phenotypes (naïve: CD44<sup>−</sup>CD62L<sup>+</sup>, central memory (CM): CD44<sup>+</sup>CD62L<sup>+</sup>, effector memory (EM): CD44<sup>+</sup>CD62L<sup>−</sup> and effector: CD44<sup>−</sup>CD62L<sup>−</sup>). Data presented as mean ± SEM and differences analyzed using paired Student’s <span class="html-italic">t</span>-test (* <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01; *** <span class="html-italic">p</span> &lt; 0.001; **** <span class="html-italic">p</span> &lt; 0.0001; ns, non-significant).</p>
Full article ">Figure 2
<p>ICOS-based co-stimulation enhances in vitro Th17 polarization of adoptive transfer (AT) Eµ-TCL1 CD4<sup>+</sup> T cells. Bulk CD4<sup>+</sup> T cells were negatively selected from AT Eµ-TCL1 splenocytes and polarized to Th17 phenotype using either anti-CD28 or anti-ICOS dynabeads for 5 days. Cells were then stimulated using PMA/ionomycin and stained for flow cytometry. (<b>A</b>) Diagram representing the establishment of the AT Eµ-TCL1 model. (<b>B</b>) Representative flow cytometry dot plots and tabulated results of IL-17A production by polarized CD4<sup>+</sup> T cells. (<b>C</b>) Frequency of IL-17<sup>hi</sup> RORγt<sup>+</sup> cells as measured by intracellular staining. (<b>D</b>,<b>E</b>) Frequency of IFNγ positive cells (<b>D</b>) and live cells (<b>E</b>) as indicated by flow cytometry analysis. (<b>F</b>) Surface expression levels of CD25. (<b>G</b>) Analysis of T-cell memory phenotypes (naïve: CD44<sup>−</sup>CD62L<sup>+</sup>, central memory (CM): CD44<sup>+</sup>CD62L<sup>+</sup>, effector memory (EM): CD44<sup>+</sup>CD62L<sup>−</sup> and effector: CD44<sup>−</sup>CD62L<sup>−</sup>). Data were presented as mean ± SD and differences were analyzed using paired Student’s <span class="html-italic">t</span>-test (** <span class="html-italic">p</span> &lt; 0.01).</p>
Full article ">Figure 3
<p>Eµ-TCL1 in vitro-polarized Th17 cells show signs of enhanced memory formation. (<b>A</b>) Representative flow cytometry dot plot showing gating on Eµ-TCL1 CD4<sup>+</sup> T-cell populations with varying levels of IL-17 expression following in vitro Th17 polarization for 5 days. (<b>B</b>–<b>E</b>) Relative expression levels of RORγt, CD25 (<b>B</b>), TCF-1 (<b>C</b>), CD127 (<b>D</b>), and CD27 (<b>E</b>) in IL-17<sup>hi</sup> populations compared to IL-17<sup>lo</sup> counterparts. (<b>F</b>) Analysis of T-cell memory phenotypes (naïve: CD44<sup>-</sup>CD62L<sup>+</sup>, central memory (CM): CD44<sup>+</sup>CD62L<sup>+</sup>, effector memory (EM): CD44<sup>+</sup>CD62L<sup>−</sup> and effector: CD44<sup>−</sup>CD62L<sup>−</sup>) in IL-17<sup>hi</sup> and IL-17<sup>lo</sup> cell populations. Data presented as mean ± SEM and differences analyzed using unpaired Student’s <span class="html-italic">t</span>-test (* <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01; **** <span class="html-italic">p</span> &lt; 0.0001; ns, non-significant).</p>
Full article ">Figure 4
<p>Eµ-TCL1 CAR Th17 cells maintain in vitro cytotoxic potential with improved persistence. (<b>A</b>) Schematic showing the timeline for the in vitro generation, polarization, and challenging of CAR Th17 cells with CD19<sup>+</sup> 3T3 target cells. Sample flow cytometry dot plots showing gating on live and dead 3T3 and CAR T cells are shown. (<b>B</b>) Representative flow cytometry dot plots showing viral transduction efficiency as indicated by percent GFP<sup>+</sup> CAR T cells. (<b>C</b>) Quantitation of percent specific lysis upon two challenges of CD19<sup>+</sup> 3T3 target cells at different effector/target (CAR T cell: 3T3 cell) ratios. (<b>D</b>) Percentage change in target cell lysis by CAR T cells between the two target cell challenges at different effector/target cell ratios. (<b>E</b>) Percentage of live GFP<sup>+</sup> CAR T cells after the first and second challenges with 3T3 target cells. Data presented as mean ± SD and differences analyzed using unpaired Student’s <span class="html-italic">t</span>-test (* <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01; *** <span class="html-italic">p</span> &lt; 0.001; **** <span class="html-italic">p</span> &lt; 0.0001).</p>
Full article ">
12 pages, 2676 KiB  
Article
Nonfullerene Small Molecular Acceptor Acting as a Solid Additive Enables Highly Efficient Pseudo-Bilayer All-Polymer Solar Cells
by Jiayin Liu, Yuheng Ni, Jiaqi Zhang, Yijun Zhao, Wenjing Xu, Xiaoling Ma and Fujun Zhang
Energies 2024, 17(11), 2623; https://doi.org/10.3390/en17112623 - 29 May 2024
Viewed by 613
Abstract
In this work, pseudo-bilayer planar heterojunction (PPHJ) all-polymer solar cells (APSCs) were constructed on the basis of the commonly used PY-IT and PM6 as the acceptor and donor, respectively. A nonfullerene small molecular acceptor (NF-SMA) BTP-eC9 was incorporated into the PY-IT layer as [...] Read more.
In this work, pseudo-bilayer planar heterojunction (PPHJ) all-polymer solar cells (APSCs) were constructed on the basis of the commonly used PY-IT and PM6 as the acceptor and donor, respectively. A nonfullerene small molecular acceptor (NF-SMA) BTP-eC9 was incorporated into the PY-IT layer as the solid additive in consideration of its similar building block to PY-IT. BTP-eC9 can serve as a photon capture reinforcer and morphology-regulating agent to realize more adequate photon capture, as well as a more orderly molecular arrangement for effective carrier transport. By incorporating 2 wt% BTP-eC9, the efficiency of PM6/PY-IT-based PPHJ-APSCs was boosted from 15.11% to 16.47%, accompanied by a synergistically enhanced short circuit current density (JSC, 23.36 vs. 24.08 mA cm−2) and fill factor (FF, 68.83% vs. 72.76%). In another all-polymer system, based on PBQx-TCl/PY-DT as the active layers, the efficiency could be boosted from 17.51% to 18.07%, enabled by the addition of 2 wt% L8-BO, which further verified the effectiveness of using an NF-SMA as a solid additive. This work demonstrates that incorporating an NF-SMA as a solid additive holds great potential for driving the development of PPHJ-APSCs. Full article
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>) Chemical construction, (<b>b</b>) HOMO and LUMO levels, (<b>c</b>) normalized absorption spectra of related materials, (<b>d</b>) absorption spectra of related layered films.</p>
Full article ">Figure 2
<p>(<b>a</b>) <span class="html-italic">J-V</span> curves and (<b>b</b>) EQE spectra of reference and optimal PPHJ-APSCs.</p>
Full article ">Figure 3
<p>(<b>a</b>) <span class="html-italic">J<sub>ph</sub></span>-<span class="html-italic">V<sub>eff</sub></span> curves, (<b>b</b>) <span class="html-italic">J<sub>SC</sub></span>-<span class="html-italic">P<sub>light</sub></span> curves, (<b>c</b>) Nyquist plots and equivalent circuit of the reference and optimal PPHJ-APSCs, (<b>d</b>) ln(JL<sup>3</sup>/V<sup>2</sup>)-(V/L)<sup>0.5</sup> curves of electron-only devices.</p>
Full article ">Figure 4
<p>(<b>a</b>) Grazing-incidence wide-angle X-ray scattering (GIWAXS) images and (<b>b</b>) GIWAXS intensity profiles along different directions for the reference and optimal films, in which black and red lines represent in-plane (IP) and out-of-plane (OOP) directions.</p>
Full article ">Figure 5
<p>(<b>a</b>) Chemical structures of PBQx-TCl, PY-DT and L8-BO, (<b>b</b>) <span class="html-italic">J-V</span> curves and (<b>c</b>) EQE spectra of typical PPHJ-APSCs.</p>
Full article ">
17 pages, 2258 KiB  
Article
Effects of Cannabidiol, ∆9-Tetrahydrocannabinol, and WIN 55-212-22 on the Viability of Canine and Human Non-Hodgkin Lymphoma Cell Lines
by Saba Omer, Suhrud Pathak, Mahmoud Mansour, Rishi Nadar, Dylan Bowen, Muralikrishnan Dhanasekaran, Satyanarayana R. Pondugula and Dawn Boothe
Biomolecules 2024, 14(4), 495; https://doi.org/10.3390/biom14040495 - 19 Apr 2024
Cited by 1 | Viewed by 1451
Abstract
In our previous study, we demonstrated the impact of overexpression of CB1 and CB2 cannabinoid receptors and the inhibitory effect of endocannabinoids (2-arachidonoylglycerol (2-AG) and Anandamide (AEA)) on canine (Canis lupus familiaris) and human (Homo sapiens) non-Hodgkin lymphoma [...] Read more.
In our previous study, we demonstrated the impact of overexpression of CB1 and CB2 cannabinoid receptors and the inhibitory effect of endocannabinoids (2-arachidonoylglycerol (2-AG) and Anandamide (AEA)) on canine (Canis lupus familiaris) and human (Homo sapiens) non-Hodgkin lymphoma (NHL) cell lines’ viability compared to cells treated with a vehicle. The purpose of this study was to demonstrate the anti-cancer effects of the phytocannabinoids, cannabidiol (CBD) and ∆9-tetrahydrocannabinol (THC), and the synthetic cannabinoid WIN 55-212-22 (WIN) in canine and human lymphoma cell lines and to compare their inhibitory effect to that of endocannabinoids. We used malignant canine B-cell lymphoma (BCL) (1771 and CLB-L1) and T-cell lymphoma (TCL) (CL-1) cell lines, and human BCL cell line (RAMOS). Our cell viability assay results demonstrated, compared to the controls, a biphasic effect (concentration range from 0.5 μM to 50 μM) with a significant reduction in cancer viability for both phytocannabinoids and the synthetic cannabinoid. However, the decrease in cell viability in the TCL CL-1 line was limited to CBD. The results of the biochemical analysis using the 1771 BCL cell line revealed a significant increase in markers of oxidative stress, inflammation, and apoptosis, and a decrease in markers of mitochondrial function in cells treated with the exogenous cannabinoids compared to the control. Based on the IC50 values, CBD was the most potent phytocannabinoid in reducing lymphoma cell viability in 1771, Ramos, and CL-1. Previously, we demonstrated the endocannabinoid AEA to be more potent than 2-AG. Our study suggests that future studies should use CBD and AEA for further cannabinoid testing as they might reduce tumor burden in malignant NHL of canines and humans. Full article
(This article belongs to the Special Issue New Advances of Cannabinoid Receptors in Health and Disease)
Show Figures

Figure 1

Figure 1
<p>Biphasic effect of the phytocannabinoids cannabidiol (CBD) and ∆9-tetrahydrocannabinol (THC) on cell viability of canine and human non-Hodgkin lymphomas. (<b>A</b>). CBD treatment of B-cell lymphomas (canine 1771 and CLBL1, and human Ramos) and canine T-cell lymphoma (CL-1). (<b>B</b>). THC treatment of B-cell lymphomas (canine 1771 and CLBL1 and human Ramos). The experiment was repeated three times at 24 and 48 h. Replica for each treatment = 12. The results are expressed as (%) change compared to the 100% cell viability in vehicle-treated control. Values over 100% are due to increased cell growth. Data are depicted as mean ± SD. Data were evaluated with analysis of variance (ANOVA), followed by Dunnett’s multiple comparison test. Of note, no biphasic effect was detected in CL-1 canine TCL cells when treated with THC (<b>B</b>). Overall, CBD demonstrated a more potent inhibitory effect on cell viability against BCL than against TCL (<b>A</b>). (* statistically significant increase/decrease in cell viability compared to the control).</p>
Full article ">Figure 2
<p>Effect of WIN on canine and human non-Hodgkin lymphoma cell viability. The WIN treatment decreased cell viability in canine and human Ramos B-cell lymphoma cell lines (1771, CLBL-1, and Ramos). No significant effects were detected in canine T-cell lymphoma cell line CL-1. The WIN treatment was at 0.5–50 µM concentrations for 24 h and 48 h. The experiment was repeated three times. Replica for each treatment = 12. The results are expressed as (%) change compared to the control, with mean ± SD. Data were evaluated using analysis of variance (ANOVA), followed by Dunnett’s multiple comparison test. (* statistically significant increase/decrease in cell viability compared to the control).</p>
Full article ">Figure 3
<p>Effect of CBD on canine healthy lymphocytes’ viability. CBD treatment caused no significant effect in canine healthy lymphocytes. CBD treatment was at concentrations of 0.1–50 µM for 24 h. Results are expressed as (%) change compared to control, with mean ± SD.</p>
Full article ">Figure 4
<p>(<b>A</b>,<b>B</b>) Effects of CBD, THC, and WIN on markers of oxidative stress in 1771 canine lymphoma cells. All markers of oxidative stress were measured spectrofluorometrically. (<b>A</b>) CBD treatment is associated with a dose-dependent increase in nitrite content, reactive oxygen species (ROS) generation, and NADH and lipid peroxidation, and a simultaneous dose-dependent decrease in the GSH content in lymphoma-treated cells when compared to the control. THC demonstrates a dose-dependent increase in lipid peroxidation and ROS content and a decrease in GSH and nitrite contents. A significant effect could not be demonstrated in the cellular content of NADH in cells treated with THC. (<b>B</b>) The synthetic cannabinoid (WIN) shows a significant dose-dependent increase in nitrite, ROS, and H<sub>2</sub>O<sub>2</sub> contents and a decrease in GSH compared to the vehicle-treated control cells. (<b>C</b>,<b>D</b>) Effects of exogenous cannabinoids on Interleukin-1β-converting enzyme (ICE-1) and cyclooxygenase (COX) activities, showing a significant increase in lymphoma cells treated with THC and WIN at a 50 µM final concentration. CBD treatment increases cox activity significantly by does not alter the ICE-1 level. The vehicle treatment (50 μM) does not affect the activity of ICE-1 or COX. The results are expressed as % change compared to the vehicle-treated control, with mean ± SD. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, <span class="html-italic">*** p &lt;</span> 0.001, **** <span class="html-italic">p</span> ≤ 0.0001. <span class="html-italic">n</span> = 5. (asterisk significant compared to the control).</p>
Full article ">Figure 5
<p>Effects of CBD, THC, and WIN on canine 1771 B-cell lymphoma cells. Caspase-3, caspase-8, and caspase-9 activities were measured spectrofluorometrically using AC-DEVD-AMC, Ac-VETD-AMC, Ac-LEHD-pNa, respectively, as the substrate. (<b>A</b>) CBD and THC increased all caspase activities in a dose-dependent manner. Significant dose-dependent effects on caspase-3 activity could not be demonstrated with CBD when compared to the control. (<b>B</b>) A significant increase in caspase-3 and caspase-9 activities was demonstrated in cells treated with WIN. The significant effect of WIN could not be demonstrated on caspase-8 activity. (<b>C</b>,<b>D</b>) Effects of CBD, THC, and WIN on canine 1771 B-cell lymphoma cells’ complex-I activity. The complex-I activity was measured spectrophotometrically using NADH as the substrate. CBD and WIN showed a significant decrease in complex-I activity compared to the control. The significant effect on complex-1 activity could not be demonstrated with THC. The results are expressed as % change compared to the control, with mean ± SD. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, **** <span class="html-italic">p</span> ≤ 0.0001. <span class="html-italic">n</span> = 5. (asterisk significant compared to the control).</p>
Full article ">
24 pages, 3383 KiB  
Review
Lipid Droplets: Formation, Degradation, and Their Role in Cellular Responses to Flavivirus Infections
by James Z. Hsia, Dongxiao Liu, LaPrecious Haynes, Ruth Cruz-Cosme and Qiyi Tang
Microorganisms 2024, 12(4), 647; https://doi.org/10.3390/microorganisms12040647 - 24 Mar 2024
Viewed by 2472
Abstract
Lipid droplets (LDs) are cellular organelles derived from the endoplasmic reticulum (ER), serving as lipid storage sites crucial for maintaining cellular lipid homeostasis. Recent attention has been drawn to their roles in viral replication and their interactions with viruses. However, the precise biological [...] Read more.
Lipid droplets (LDs) are cellular organelles derived from the endoplasmic reticulum (ER), serving as lipid storage sites crucial for maintaining cellular lipid homeostasis. Recent attention has been drawn to their roles in viral replication and their interactions with viruses. However, the precise biological functions of LDs in viral replication and pathogenesis remain incompletely understood. To elucidate the interaction between LDs and viruses, it is imperative to comprehend the biogenesis of LDs and their dynamic interactions with other organelles. In this review, we explore the intricate pathways involved in LD biogenies within the cytoplasm, encompassing the uptake of fatty acid from nutrients facilitated by CD36-mediated membranous protein (FABP/FATP)-FA complexes, and FA synthesis via glycolysis in the cytoplasm and the TCL cycle in mitochondria. While LD biogenesis primarily occurs in the ER, matured LDs are intricately linked to multiple organelles. Viral infections can lead to diverse consequences in terms of LD status within cells post-infection, potentially involving the breakdown of LDs through the activation of lipophagy. However, the exact mechanisms underlying LD destruction or accumulation by viruses remain elusive. The significance of LDs in viral replication renders them effective targets for developing broad-spectrum antivirals. Moreover, considering that reducing neutral lipids in LDs is a strategy for anti-obesity treatment, LD depletion may not pose harm to cells. This presents LDs as promising antiviral targets for developing therapeutics that are minimally or non-toxic to the host. Full article
(This article belongs to the Special Issue Emerging Viral Zoonoses)
Show Figures

Figure 1

Figure 1
<p>A schematic model of LD biogenesis. FA, serving as the material for TAG synthesis in the ER, is acquired through the CD36-mediated pathway or produced from Acetyl-CoA by ACC and FASN. Acetyl-CoA is generated from citrate, a product of glucose breakdown in the mitochondrion. FA-CoA and G-3-P (a product from glycolysis) participate in the de novo synthesis of TAG in the ER. CE is formed from cholesterol, a component of LDL sensed by SREBP/SCAP, and Acyl-CoA. Finally, LDs are biogenesized and released to the cytosol and surrounded by various cellular proteins. <b>Abbreviations.</b> LDs, lipid droplets; ER, endoplasmic reticulum; Mito, mitochondria; FA, fatty acid; ACSL, long-chain-fatty-acid—CoA ligase; Acyl-CoA, acyl coenzyme A; G-3-P, glycerol-3-phosphate; GPAT, glycerol-3 phosphate acyltransferase; LPA, lysophosphatidic acid; AGPAT, acylglycerolphosphate acyltransferase; PA, phosphatidic acid; PAP, phosphatidic acid phosphatase; DAG, diacylglycerol; DGAT, acyl-CoA:diacylglycerol acyltransferase; TAG, triacylglycerol; Plin, perilipin; LDL, low-density lipoprotein; CE, cholesterol ester; ATGL, adipocyte triglyceride lipase; MAGL, monoacylglycerol lipase; HSL, hormone-sensitive lipase; CGI-58, comparative gene identification-58; SREBP, sterol regulatory element-binding protein; SCAP, SREBP1 cleavage-activating protein; ACC, Acetyl-CoA Carboxylase; FASN, fatty acid synthase; TIP47, Tail-interacting protein 47 (also called Plin3), TCA, tricarboxylic acid; OAA, oxyloacetic acid; P, phosphate; ACL, ATP citrate lyase; ACC, acetyl-CoA carboxylase; FAS, fatty acid synthase; HMG, 3-hydroxy-3-methylglutaryl; HMGCR, HMG-CoA reductase; FACS, fatty acyl-CoA synthetase; FATP, fatty acid transport protein; FABP, fatty acid-binding protein.</p>
Full article ">Figure 2
<p><b>Lipolysis of LDs:</b> Perilipin 1 (Plin1) binds with CGI-58 to keep it away from ATGL, HSL, and MAGL so that the lipases are at an inactive state and LDs maintain intact (left); several conditions such as starvation, viral infection, the demanding of membrane generation, and stress activate PKA that phosphorylates Plin1, leading its degradation (right). In this case, CGI-58 is freed to bind ATGL, HSL, and MAGL causing their phosphorylation and activation to enter the LD core to lysate TAG and DAG to release FAs and from MAG that is catalyzed to produce glycerol and FAs. <b>Abbreviations</b>. pPlin, phosphorylated Plin; PKA, protein kinase A.</p>
Full article ">Figure 3
<p>Lipophagy of LDs. Upper panel. Macrophagy of LD lipophagy: (1) Preautophagosome assembly, initiation site of phagosome formation with molecular activation cascade (blue box). (2) phagophore membrane expansion to surround LDs, (3) vesicle elongation, (4) vesicle nucleation to form closed autophagosome, and (5) fusion of matured autophagosomes with lysosome. Lower panel. Chaperone-mediated autophagy depends on interactions of LAMP2A and HSC70, resulting in degradation of Plin2 and Plin3 (purple box) and LDs. <b>Abbreviations</b>. AMPK, AMP-activated protein kinase; AMP, adenosine monophosphate; ATP, adenosine triphosphate; PPAR, peroxisome proliferator-activated receptor; CaMKKβ, Ca(2+)/CaM-dependent protein kinase kinase β; ULK-1, Unc-51-like kinase 1; PI3KC3, phosphatidylinositol (PI)3-kinase complexes 3; PI(3)P, Phosphatidylinositol 3-phosphate; LAMP-2A, lysosome protein 2A; CMA, chaperone-mediated autophagy; HSC70, Heat shock cognate 71 kDa protein.</p>
Full article ">Figure 4
<p>Zika virus replication cycle. ZIKV entry, trafficking to ER for viral replication, assembly, and maturation in Golgi apparatus and release outside of cells.</p>
Full article ">Figure 5
<p>LD metabolism for viral replication within the infected cells. Upon viral infection into a permissive cell, unknown (?) viral effects and factors reprogram LDs to provide necessary materials for viral replication: (1) FA for generating ATP in the mitochondrion and (2) CE/SM/PC for establishing viral replication compartment and viral assembly. <b>Abbreviations</b>. ATP, adenosine triphosphate; FASN or FAS, fatty acid synthase; CPT1, carnitine palmitoyltransferase 1; FACS, fatty acyl-CoA synthase; CAT, carnitine translocase; PPL, phospholipid; SM, sphingomyelin; PC, phosphatidylcholine; vProtein, viral protein.</p>
Full article ">
15 pages, 2315 KiB  
Article
Effect of Light Quality on Seed Potato (Solanum tuberose L.) Tuberization When Aeroponically Grown in a Controlled Greenhouse
by Md Hafizur Rahman, Md. Jahirul Islam, Umma Habiba Mumu, Byeong Ryeol Ryu, Jung-Dae Lim, Md Obyedul Kalam Azad, Eun Ju Cheong and Young-Seok Lim
Plants 2024, 13(5), 737; https://doi.org/10.3390/plants13050737 - 6 Mar 2024
Cited by 2 | Viewed by 1312
Abstract
A plant factory equipped with artificial lights is a comparatively new concept when growing seed potatoes (Solanum tuberosum L.) for minituber production. The shortage of disease-free potato seed tubers is a key challenge to producing quality potatoes. Quality seed tuber production all [...] Read more.
A plant factory equipped with artificial lights is a comparatively new concept when growing seed potatoes (Solanum tuberosum L.) for minituber production. The shortage of disease-free potato seed tubers is a key challenge to producing quality potatoes. Quality seed tuber production all year round in a controlled environment under an artificial light condition was the main purpose of this study. The present study was conducted in a plant factory to investigate the effects of distinct spectrum compositions of LEDs on potato tuberization when grown in an aeroponic system. The study was equipped with eight LED light combinations: L1 = red: blue: green (70 + 25 + 5), L2 = red: blue: green (70 + 20 + 10), L3 = red: blue: green (70 + 15 + 15), L4 = red: blue: green (70 + 10 + 20), L5 = red: blue: far-red (70 + 25 + 5), L6 = red: blue: far-red (70 + 20 + 10), L7 = red: blue: far-red (70 + 15 + 15), L8 = red: blue: far-red (70 + 10 + 20), and L9 = natural light with 300 µmol m−2 s−1 of irradiance, 16/8 h day/night, 65% relative humidity, while natural light was used as the control treatment. According to the findings, treatment L4 recorded a higher tuber number (31/plant), tuber size (>3 g); (9.26 ± 3.01), and GA3 content, along with better plant growth characteristics. Moreover, treatment L4 recorded a significantly increased trend in the stem diameter (11.08 ± 0.25), leaf number (25.32 ± 1.2), leaf width (19 ± 0.81), root length (49 ± 2.1), and stolon length (49.62 ± 2.05) compared to the control (L9). However, the L9 treatment showed the best performance in plant fresh weight (67.16 ± 4.06 g) and plant dry weight (4.46 ± 0.08 g). In addition, photosynthetic pigments (Chl a) (0.096 ± 0.00 mg g−1, 0.093 ± 0.00 mg g−1) were found to be the highest in the L1 and L2 treatments, respectively. However, Chl b and TCL recorded the best results in treatment L4. Finally, with consideration of the plant growth and tuber yield performance, treatment L4 was found to have the best spectral composition to grow quality seed potato tubers. Full article
(This article belongs to the Special Issue Light and Its Influence on the Growth and Quality of Plants)
Show Figures

Figure 1

Figure 1
<p>Photographs of potato plants grown under different artificial LED light spectrums.</p>
Full article ">Figure 2
<p>Tuber yield of potatoes grown under different LEDs light spectra in the aeroponic culture system. Significant differences (<span class="html-italic">p</span> &lt; 0.05) are indicated by different letters in each bar graph. L1 = red: blue: green (70 + 25 + 5), L2 = red: blue: green (70 + 20 + 10), L3 = red: blue: green (70 + 15 + 15), L4 = red: blue: green (70 + 10 + 20), L5 = red: blue: far-red (70 + 25 + 5), L6 = red: blue: far-red (70 + 20 + 10), L7 = red: blue: far-red (70 + 15 + 15), L8 = red: blue: far-red (70 + 10 + 20), L9 = natural light.</p>
Full article ">Figure 3
<p>Tuber grading of potato grown under different LEDs light spectra in the aeroponic culture system. Significant differences (<span class="html-italic">p</span> &lt; 0.05) are indicated by different letters in each bar graph. L1 = red: blue: green (70 + 25 + 5), L2 = red: blue: green (70 + 20 + 10), L3 = red: blue: green (70 + 15 + 15), L4 = red: blue: green (70 + 10 + 20), L5 = red: blue: far-red (70 + 25 + 5), L6 = red: blue: far-red (70 + 20 + 10), L7 = red: blue: far-red (70 + 15 + 15), L8 = red: blue: far-red (70 + 10 + 20), L9 = natural light.</p>
Full article ">Figure 4
<p>Net photosynthetic rate (A), transpiration rate (E), stomatal conductance (gs), and water use efficiency (WUE) of potato plants grown different LEDs light spectra in an aeroponic culture system. Significant differences (<span class="html-italic">p</span> &lt; 0.05) are indicated by different letters in each bar graph. L1 = red: blue: green (70 + 25 + 5), L2 = red: blue: green (70 + 20 + 10), L3 = red: blue: green (70 + 15 + 15), L4 = red: blue: green (70 + 10 + 20), L5 = red: blue: far-red (70 + 25 + 5), L6 = red: blue: far-red (70 + 20 + 10), L7 = red: blue: far-red (70 + 15 + 15), L8 = red: blue: far-red (70 + 10 + 20), L9 = natural light.</p>
Full article ">Figure 5
<p>Chlorophyll <span class="html-italic">a</span> (Chl <span class="html-italic">a</span>), chlorophyll <span class="html-italic">b</span> (Chl <span class="html-italic">b</span>), total chlorophyll (TCL), carotenoid (car) and SPAD index of potato plants grown under different LED light spectra in an aeroponic culture system. Significant differences (<span class="html-italic">p</span> &lt; 0.05) are indicated by different letters in each bar graph. L1 = red: blue: green (70 + 25 + 5), L2 = red: blue: green (70 + 20 + 10), L3 = red: blue: green (70 + 15 + 15), L4 = red: blue: green (70 + 10 + 20), L5 = red: blue: far-red (70 + 25 + 5), L6 = red: blue: far-red (70 + 20 + 10), L7 = red: blue: far-red (70 + 15 + 15), L8 = red: blue: far-red (70 + 10 + 20), L9 = natural light.</p>
Full article ">Figure 6
<p>The GA3 content of potato plants grown in an aeroponic system. Significant differences (<span class="html-italic">p</span> &lt; 0.05) are indicated by different letters in each bar graph. L1 = red: blue: green (70 + 25 + 5), L2 = red: blue: green (70 + 20 + 10), L3 = red: blue: green (70 + 15 + 15), L4 = red: blue: green (70 + 10 + 20), L5 = red: blue: far-red (70 + 25 + 5), L6 = red: blue: far-red (70 + 20 + 10), L7 = red: blue: far-red (70 + 15 + 15), L8 = red: blue: far-red (70 + 10 + 20), L9 = natural light.</p>
Full article ">Figure 7
<p>Patterns and associations between treatments are represented by principal component analysis (PCA). Stem L. (Stem length); stem dia. (stem diameter); leaf N. (leaf number); leaf L. (leaf length); leaf W. (leaf width); branch N. (branch number); root L. (root length); stolon L. (stolon length); PFW (plant fresh weight); PDW (plant dry weight); A (photosynthetic rate); E (transpiration rate); gs (stomatal conductance); WUE (water use efficiency); Chl <span class="html-italic">a</span> (chlorophyll <span class="html-italic">a</span>); Chl <span class="html-italic">b</span> (chlorophyll <span class="html-italic">b</span>); Tch (total chlorophyll); Car (carotenoid); SPAD index; GA3 (gibberellic acid content) tuber N. (tuber number); tuber FW. (tuber fresh weight); tuber N. (tuber number); TFW (tuber fresh weight); &lt;1 g, (less than 1 g); &gt;1 g, (more than 1 g); &gt;3 g (more than 3 g).</p>
Full article ">
18 pages, 3665 KiB  
Article
Global Sensitivity Analysis of Factors Influencing the Surface Temperature of Mold during Autoclave Processing
by Jiayang He, Lihua Zhan, Youliang Yang and Yongqian Xu
Polymers 2024, 16(5), 705; https://doi.org/10.3390/polym16050705 - 5 Mar 2024
Viewed by 881
Abstract
During the process of forming carbon fiber reinforced plastics (CFRP) in an autoclave, deeply understanding the global sensitivity of factors influencing mold surface temperature is of paramount importance for optimizing large frame-type mold thermally and enhancing curing quality. In this study, the convective [...] Read more.
During the process of forming carbon fiber reinforced plastics (CFRP) in an autoclave, deeply understanding the global sensitivity of factors influencing mold surface temperature is of paramount importance for optimizing large frame-type mold thermally and enhancing curing quality. In this study, the convective heat transfer coefficient (CHTC), the thickness of composite laminates (TCL), the thickness of mold facesheet (TMF), the mold material type (MMT), and the thickness of the auxiliary materials layer (TAL) have been quantitatively assessed for the effects on the mold surface temperature. This assessment was conducted by building the thermal–chemical curing model of composite laminates and utilizing the Sobol global sensitivity analysis (GSA) method. Additionally, the interactions among these factors were investigated to gain a comprehensive understanding of their combined effects. The results show that the sensitivity order of these factors is as follows: CHTC > MMT > TMF > TCL > TAL. Moreover, CHTC, MMT, and TMF are the main factors influencing mold surface temperature, as the sum of their first-order sensitivity indices accounts for over 97.3%. The influence of a single factor is more significant than that of the interaction between factors since the sum of the first-order sensitivity indices of the factors is more than 78.1%. This study will support the development of science-based guidelines for the thermal design of molds and associated heating equipment design. Full article
(This article belongs to the Section Polymer Processing and Engineering)
Show Figures

Figure 1

Figure 1
<p>Preparation of composite laminates and mold for autoclave processing.</p>
Full article ">Figure 2
<p>Temperature and pressure profiles of the curing process.</p>
Full article ">Figure 3
<p>Schematic of composite laminates dimensions and layup orientation.</p>
Full article ">Figure 4
<p>Schematic of thermocouples arrangement.</p>
Full article ">Figure 5
<p>The FE model for curing process of the composite laminates: (<b>a</b>) description of mesh and temperature monitoring locations; (<b>b</b>) description of boundary condition.</p>
Full article ">Figure 6
<p>Temperature boundary conditions of the FE model for the laminates curing process: (<b>a</b>) <span class="html-italic">T</span><sub>1</sub>; (<b>b</b>) <span class="html-italic">T</span><sub>2</sub>.</p>
Full article ">Figure 7
<p>Comparison results and deviation between experiment and simulation: (<b>a</b>) 3#; (<b>b</b>) 4#; (<b>c</b>) 5#.</p>
Full article ">Figure 8
<p>The FE model of curing process for auxiliary materials-laminates-mold: (<b>a</b>) description of mesh and layers thicknesses; (<b>b</b>) description of boundary condition.</p>
Full article ">Figure 9
<p>Schematic diagram of the output variable <span class="html-italic">Y</span>.</p>
Full article ">Figure 10
<p>Sensitivity indices, with 95% confidence bounds, and for parameters within the default ranges: (<b>a</b>) first-order sensitivity indices; (<b>b</b>) total-order sensitivity indices; (<b>c</b>) interaction sensitivity indices.</p>
Full article ">Figure 11
<p>Second-order sensitivity indices between five parameters within the default ranges.</p>
Full article ">Figure 12
<p>Sensitivity indices of parameters with 95% confidence bounds: (<b>a</b>) first-order sensitivity indices for different ranges of TAL and TCL; (<b>b</b>) total-order sensitivity indices for different ranges of TAL and TCL.</p>
Full article ">Figure 13
<p>Second-order sensitivity indices between five parameters based on different ranges of TAL and TCL: (<b>a</b>) <span class="html-italic">δ</span><sub>1</sub> ∈ [1, 13], <span class="html-italic">δ</span><sub>2</sub> ∈ [1, 39]; (<b>b</b>) <span class="html-italic">δ</span><sub>1</sub> ∈ [1, 19], <span class="html-italic">δ</span><sub>2</sub> ∈ [1, 58]; (<b>c</b>) <span class="html-italic">δ</span><sub>1</sub> ∈ [1, 25], <span class="html-italic">δ</span><sub>2</sub> ∈ [1, 77].</p>
Full article ">Figure 14
<p>Sensitivity indices of parameters with 95% confidence bounds: (<b>a</b>) first-order sensitivity indices for different ranges of <span class="html-italic">h</span>; (<b>b</b>) total-order sensitivity indices for different ranges of <span class="html-italic">h</span>.</p>
Full article ">Figure 15
<p>Second-order sensitivity indices between five parameters based on different ranges of CHTC: (<b>a</b>) <span class="html-italic">h</span> ∈ [10, 155]; (<b>b</b>) <span class="html-italic">h</span> ∈ [155, 300].</p>
Full article ">
19 pages, 3224 KiB  
Article
Low-Voltage Distribution Network Loss-Reduction Method Based on Load-Timing Characteristics and Adjustment Capabilities
by Cheng Huangfu, Erwei Wang, Ting Yi and Liang Qin
Energies 2024, 17(5), 1115; https://doi.org/10.3390/en17051115 - 26 Feb 2024
Viewed by 700
Abstract
The primary contributors to elevated line losses in low-voltage distribution networks are three-phase load imbalances and variations in load peak–valley differentials. The conventional manual phase sequence adjustment fails to capitalize on the temporal characteristics of the load, and the proliferation of smart homes [...] Read more.
The primary contributors to elevated line losses in low-voltage distribution networks are three-phase load imbalances and variations in load peak–valley differentials. The conventional manual phase sequence adjustment fails to capitalize on the temporal characteristics of the load, and the proliferation of smart homes has opened up new scheduling possibilities for managing the load. Consequently, this paper introduces a loss-reduction method for low-voltage distribution networks that leverages load-timing characteristics and adjustment capabilities. This method combines dynamic and static methods to reduce energy consumption from different time scales. To commence, this paper introduced a hierarchical fuzzy C-means algorithm (H-FCM), taking into account the distance and similarity of load curves. Subsequently, a phase sequence adjustment method, grounded in load-timing characteristics, was developed. The typical user load curve, derived from the classification of user loads, serves as the foundation for constructing a long-term commutation model, therefore mitigating the impact of load fluctuations on artificial commutation. Following this, this paper addressed the interruptible and transferable characteristics of various smart homes. This paper proposed a multi-objective transferable load (TL) optimal timing task adjustment model and a peak-shaving control strategy specifically designed for maximum sustainable power reduction of temperature-controlled loads (TCL). These strategies aim to achieve real-time load adjustment, correct static commutation errors, and reduce peak-to-valley differences. Finally, a simulation verification model was established in MATLAB (R2022a). The results show that the proposed method mainly solves the problems of three-phase imbalance and large load peak–valley difference in low-voltage distribution networks and reduces the line loss of low-voltage distribution networks through manual commutation and load adjustment. Full article
Show Figures

Figure 1

Figure 1
<p>Overall plan flow chart.</p>
Full article ">Figure 2
<p>HEMS system structure including distributed photovoltaic power supply.</p>
Full article ">Figure 3
<p>Equivalent thermodynamic parameter model of a single residential air conditioner. Where <math display="inline"><semantics> <mrow> <msup> <mrow> <mi>θ</mi> </mrow> <mrow> <mi mathvariant="normal">i</mi> <mi mathvariant="normal">n</mi> </mrow> </msup> </mrow> </semantics></math>, <math display="inline"><semantics> <mrow> <msup> <mrow> <mi>θ</mi> </mrow> <mrow> <mi mathvariant="normal">w</mi> <mi mathvariant="normal">a</mi> <mi mathvariant="normal">l</mi> <mi mathvariant="normal">l</mi> </mrow> </msup> </mrow> </semantics></math>, <math display="inline"><semantics> <mrow> <msup> <mrow> <mi>θ</mi> </mrow> <mrow> <mi mathvariant="normal">o</mi> <mi mathvariant="normal">u</mi> <mi mathvariant="normal">t</mi> </mrow> </msup> </mrow> </semantics></math> represent indoor temperature, wall temperature, and outdoor temperature, respectively; <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>R</mi> </mrow> <mrow> <mn>1</mn> </mrow> </msub> </mrow> </semantics></math> is the equivalent resistance of indoor air and the inside of the wall, <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>R</mi> </mrow> <mrow> <mn>2</mn> </mrow> </msub> </mrow> </semantics></math> is the equivalent resistance of the outside of the wall and outdoor air; <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>C</mi> </mrow> <mrow> <mi mathvariant="normal">i</mi> <mi mathvariant="normal">n</mi> </mrow> </msub> </mrow> </semantics></math>, <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>C</mi> </mrow> <mrow> <mi mathvariant="normal">o</mi> <mi mathvariant="normal">u</mi> <mi mathvariant="normal">t</mi> </mrow> </msub> </mrow> </semantics></math> are the indoor air equivalent heat capacity and the wall equivalent heat capacity, respectively, <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>P</mi> </mrow> <mrow> <mi mathvariant="normal">c</mi> <mi mathvariant="normal">o</mi> <mi mathvariant="normal">l</mi> <mi mathvariant="normal">d</mi> </mrow> </msub> </mrow> </semantics></math> is the cooling power of the air conditioner.</p>
Full article ">Figure 4
<p>Dynamic change process of room temperature when air conditioner is working. Where <math display="inline"><semantics> <mrow> <mi>j</mi> </mrow> </semantics></math> is the index of the TCL device, <math display="inline"><semantics> <mrow> <msubsup> <mrow> <mi>I</mi> </mrow> <mrow> <mi>j</mi> </mrow> <mrow> <mi mathvariant="normal">F</mi> <mi mathvariant="normal">L</mi> <mi mathvariant="normal">A</mi> <mi mathvariant="normal">G</mi> </mrow> </msubsup> </mrow> </semantics></math> is the working status of the motor inside the TCL device <math display="inline"><semantics> <mrow> <mi>j</mi> </mrow> </semantics></math>, where 1 indicates the motor is working, and 0 indicates the motor is not working.</p>
Full article ">Figure 5
<p>H-FCM algorithm flow chart. Where <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>N</mi> </mrow> <mrow> <mi>b</mi> </mrow> </msub> </mrow> </semantics></math> is the number of users in the data set to be classified, <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>N</mi> </mrow> <mrow> <mi mathvariant="normal">m</mi> <mi mathvariant="normal">i</mi> <mi mathvariant="normal">n</mi> </mrow> </msub> </mrow> </semantics></math> is the minimum number of classified users, <math display="inline"><semantics> <mrow> <mi>σ</mi> </mrow> </semantics></math> is the square matrix obtained by calculating the sequence variance of the cluster center between two different user clusters, <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>σ</mi> </mrow> <mrow> <mi>b</mi> </mrow> </msub> </mrow> </semantics></math> is the sequence variance threshold used to assess the similarity of the curves and determine whether the algorithm setting is met. In this article, it is uniformly set as the average value of <math display="inline"><semantics> <mrow> <msub> <mrow> <mi>σ</mi> </mrow> <mrow> <mi>i</mi> <mi>n</mi> </mrow> </msub> </mrow> </semantics></math> obtained after using FCM clustering for the first time. The updated clustering center of the new user cluster is determined by weighting the clustering center of the original user cluster, with the weight being the number of user clusters.</p>
Full article ">Figure 6
<p>TCL maximum sustainable reduction power load peak-shaving control strategy.</p>
Full article ">Figure 7
<p>Various types of load curves after clustering. Where the black dots are normalized load values, and the red lines are typical load curves.</p>
Full article ">Figure 8
<p>The algorithm evolution process when solving the long-term commutation model.</p>
Full article ">Figure 9
<p>Algorithm evolution process when solving TL timing optimization model.</p>
Full article ">Figure 10
<p>Comparison of average temperatures before and after TCL adjustment.</p>
Full article ">Figure 11
<p>Histogram of switching times where TCL motor participates in regulation.</p>
Full article ">Figure 12
<p>Comparison of instantaneous three-phase imbalance at different stages.</p>
Full article ">Figure 13
<p>Comparison of instantaneous power loss at different stages.</p>
Full article ">
Back to TopTop